Structure completes $512.7M follow-on offering on NASDAQ

Structure Therapeutics

Structure Therapeutics completed a follow-on offering raising $512.7 million, further strengthening its balance sheet for Phase III trials.

• Follow-on offering raised $512.7 million.
• Proceeds support Phase III clinical program expansion.
• Multiple equity raises show strong investor interest in oral GLP-1 market.